Evolv Technologies Holdings, Inc. (EVLV)

Executive Summary / Key Takeaways

• Evolv Technologies is executing a foundational shift from a hardware-centric distributor model to direct fulfillment of purchase subscriptions, creating near-term margin pressure but driving 21% ARR growth that management expects to accelerate to 25% in 2026, building a durable recurring revenue base in a market being transformed by regulatory mandates.

• The company has emerged from a regulatory overhang with minimal damage—only 5 of 65 eligible education customers cancelled contracts following the FTC settlement—while securing a $75 million non-dilutive credit facility and achieving positive adjusted EBITDA of $11.1 million in 2025, demonstrating financial resilience during a strategic pivot.

• Weapons detection is evolving from discretionary security spending to mandatory infrastructure, with California requiring hospitals to implement automated screening by March 2027 and Georgia considering statewide school mandates, creating a TAM of nearly 400,000 sites where Evolv's 8,000 current deployments represent less than 2% penetration.

• Evolv's proprietary AI-sensor fusion technology delivers materially higher throughput than traditional screening, enabling venues to screen 4 million people daily without creating bottlenecks, but the company remains subscale compared to incumbents like OSI Systems (OSIS) and Smiths Detection (SMIN.L), creating execution risk as it ramps production with new contract manufacturer Plexus (PLXS).

• Trading at 7.4x sales with negative profit margins but positive EBITDA inflection, the stock prices in execution of the subscription model and margin expansion to high-single digits in 2026, making the investment thesis sensitive to ARR growth acceleration and cash flow generation in the second half of 2026.

Setting the Scene: From Hardware Vendor to Security Infrastructure Platform

Evolv Technologies, founded in 2013, began as a hardware company commercializing AI-powered weapons detection through its Evolv Express system, which launched in October 2019 and has since screened over four billion visitors worldwide. This origin story explains the company's current strategic pivot: having proven its technology in high-traffic venues, Evolv is now transforming from a capital equipment vendor into a Security-as-a-Service platform that monetizes through multi-year subscriptions. The company went public via SPAC in July 2021, but the real inflection point came in mid-2025 when management made the decisive move to bring purchase subscription fulfillment in-house, phasing out a legacy distributor licensing agreement with Columbia Tech that expired December 31, 2025.

This shift fundamentally alters Evolv's position in the security screening value chain. Traditional players like OSI Systems and Smiths Detection operate as hardware manufacturers selling scanners to governments and airports, generating revenue through one-time equipment sales with modest service attachments. Evolv's model integrates proprietary sensor hardware, AI-powered software, cloud connectivity, and ongoing services into a unified subscription offering. This transforms a transactional sale into a recurring relationship, increasing customer lifetime value while creating switching costs that deepen moats. The company now serves six primary verticals—education, healthcare, sports, live entertainment, tourist attractions, and houses of worship—each representing a distinct procurement dynamic but unified by a common need: screening high volumes of people and bags without creating friction or bottlenecks.

The industry structure is undergoing a secular shift driven by two forces: escalating gun violence and emerging regulatory mandates that drive demand. California's new law requiring hospitals to implement automated weapons detection by March 2027 creates a forced adoption curve in a vertical where Evolv has low single-digit penetration. Similarly, Georgia's proposed school legislation would mandate screening in all schools, a market where Evolv already screens 850,000 students daily across 1,300 buildings but represents only 1% of total U.S. school buildings. This regulatory dynamic converts discretionary security budgets into non-discretionary compliance spending, fundamentally altering the sales cycle from education-based to requirement-driven. The security screening market is projected to reach $22 billion by 2034, growing at 9.4% CAGR, but Evolv's AI-native approach positions it to capture share in civilian venues where throughput and user experience are prioritized over the absolute detection precision required in airport environments.

Technology, Products, and Strategic Differentiation: The AI-Sensor Fusion Moat

Evolv's core technology advantage lies in its proprietary AI-sensor fusion stack that combines millimeter-wave sensors , magnetic fields, and machine learning to detect concealed weapons while allowing visitors to walk through at normal pace without emptying pockets. This solves the fundamental trade-off in security screening: the tension between detection effectiveness and operational efficiency. Traditional metal detectors from competitors like Garrett create bottlenecks and high false alarm rates, while X-ray systems from OSI Systems and Smiths require trained operators and bag divestment. Evolv's Express system screens unstructured flows, reducing labor costs and improving visitor experience—a critical differentiator in venues where throughput directly impacts revenue.

The September 2024 launch of Evolv eXpedite, an autonomous AI-based bag screening solution, extends this moat into the adjacent bag screening market. Early deployments show a 2% alert rate, demonstrating strong promise in balancing threat detection with low false alarms. The product traction is notable: in Q3 2025, 12 new customers adopted eXpedite with 11 also purchasing Express; in Q4, 16 new customers bought eXpedite with 11 adding Express. This creates a land-and-expand dynamic within accounts, increasing average revenue per customer while deepening integration. More importantly, eXpedite operates at subscale manufacturing cost in 2025, creating a gross margin headwind that management expects to improve in 2026 as production ramps—this temporary margin compression is the price of establishing a second platform that doubles Evolv's addressable spend per entrance.

The company's end-to-end control of its technology stack creates a defensible moat that competitors cannot easily replicate. As CEO John Kedzierski emphasizes, the company has spent more than a decade building its full solution stack. This enables continuous improvement through anonymized screening data that trains proprietary AI models, creating network effects where each deployment makes the system smarter. The cloud-based Evolv Insights analytics platform provides customers with operational visibility into throughput volumes, alarm statistics, and system performance, making the solution stickier while generating high-margin service revenue at 71% gross margin. This data flywheel is a capability traditional hardware manufacturers like OSIS and Smiths are not currently architected to match.

The Gen2 Express platform upgrade cycle further strengthens this moat. Management reports a strong trend of existing customers upgrading before their initial Gen1 contracts expire, typically signing new four-year commitments that increase Remaining Performance Obligation (RPO). This demonstrates that customers see sufficient value to re-commit early, reducing churn risk while expanding contract values. The Evolv Flex program, launched in Q2 2025 to repurpose returned units as Certified Pre-Owned systems, targets price-sensitive buyers and expands market segments without requiring new hardware production—an efficient capital strategy that improves asset utilization while maintaining subscription revenue streams.

Financial Performance & Segment Dynamics: Evidence of Model Leverage

Evolv's 2025 financial results provide evidence that the strategic pivot is progressing. Total revenue grew 40% to $145.9 million, but the composition reveals the model transformation. Product revenue surged 235% to $21.6 million, driven by the shift to direct purchase subscription fulfillment and a $3.8 million contract with Gwinnett County Public Schools. This creates a near-term revenue acceleration that outpaces unit growth, but it also compresses gross margins to 12% from 66% in 2024. The margin compression is a planned investment in capturing higher lifetime value. The direct fulfillment model delivers higher gross profit dollars, ARR, RPO, and cash flow over the contract life compared to the legacy distribution model, even though it front-loads hardware revenue at lower margins.

Subscription revenue grew 29% to $83.8 million with stable 56% gross margins, while service revenue increased 25% to $29.4 million with margins declining from 78% to 71% due to a $1 million field services accrual and increased software amortization. This margin decline reflects the cost of scaling the installed base, but the 71% service margin remains attractive and demonstrates the recurring revenue quality. The license fee and other revenue stream, which includes the legacy distributor agreement, grew 24% to $11.1 million with 89% margins, but this will decline as the direct model replaces it.

Annual Recurring Revenue (ARR) of $120.5 million, up 21%, is a primary metric for evaluating Evolv's progress. Management expects ARR growth to accelerate throughout 2026, outpacing total revenue growth for the first time—an inflection point that signals the subscription model is scaling. The guidance for $145-150 million ARR by year-end 2026 implies 20-25% growth, which demonstrates that the direct fulfillment shift is creating durable recurring value despite near-term revenue mix noise. The RPO of $293.6 million, up 13%, provides multi-year revenue visibility.

The adjusted EBITDA inflection from a $21 million loss in 2024 to a positive $11.1 million in 2025, representing a $32 million improvement, validates the operating leverage in the model. This shows that revenue growth is translating to profitability despite the margin headwinds from model mix. The company reported five consecutive quarters of positive adjusted EBITDA, with Q4 2025 margins expanding into high single digits. The operating expense discipline is evident: Q4 2025 expenses grew only 3% year-over-year while revenue grew 32%, and full-year 2025 headcount remained flat as the company insourced work previously done by consultants.

Cash flow generation remains a financial risk. Operating cash flow turned positive at $18.7 million in 2025 versus a $30.9 million outflow in 2024, but free cash flow was negative $12.7 million due to capital expenditures. The company ended 2025 with $69 million in cash and marketable securities against $30 million in outstanding debt, with an additional $45 million available under the new credit facility. This liquidity position provides runway through 2026, but management's guidance for cash flow positivity in the second half of 2026 is a critical milestone. The Q1 2025 cash burn of $17 million due to one-time investigation and incentive payments shows how quickly cash can decline, making the H2 2026 target a key monitoring point.

Outlook, Management Guidance, and Execution Risk

Management's 2026 guidance reflects confidence in the subscription model's scalability. Revenue guidance of $172-178 million (18-22% growth) was raised from the prior $160-165 million range, driven by strong new customer acquisition and expansion within existing accounts. This suggests the sales engine is functioning, though the 18-22% revenue growth is more moderate than 2025's 40% pace as recurring revenue compounds.

The ARR guidance is more aggressive: exiting 2026 with $145-150 million implies 20-25% growth, accelerating from 2025's 21% pace. This acceleration validates the core thesis that direct fulfillment and pricing changes will drive higher-quality revenue. However, the assumed 50-50 mix between purchase and pure subscription creates execution risk—if customers prefer purchase subscriptions, ARR growth could vary from targets despite healthy total revenue.

The unit deployment target of "comfortably over 10,000" by end of 2026, up from 8,000 at 2025 year-end, implies at least 25% unit growth. This shows the company is maintaining market penetration, but it also means capital intensity will remain elevated. The Plexus manufacturing partnership, expected to fully ramp in H2 2026, is critical to achieving this scale while managing costs.

Adjusted EBITDA margin guidance for high single digits in 2026 includes a $1 million headwind from memory chip costs, showing management is accounting for supply chain pressures while still expecting expansion. The commentary that there is potential for greater long-term leverage suggests upside to margins if the model scales efficiently.

The decision to discontinue disclosing units shipped starting January 1, 2026, signals a strategic shift away from hardware metrics toward recurring revenue quality. While management argues units are no longer consistently indicative of prospects due to increasing activity in short-term subscriptions and upgrades, this change makes it more difficult to track the underlying health of the installed base.

Risks and Asymmetries: What Could Break the Thesis

The most material risk to Evolv's investment thesis is execution failure on the subscription model transition at scale. The direct fulfillment shift creates a complex operational challenge: managing hardware logistics, installation, and service delivery while maintaining the 71% service margins that drive profitability. If the company cannot efficiently scale its field operations, the higher lifetime value of direct contracts could be eroded by elevated delivery costs.

Supply chain concentration with Plexus Corp. represents a vulnerability. While the non-exclusive manufacturing agreement enhances scalability and geographic diversification, the full production ramp is not expected until H2 2026. Any disruptions in onboarding, logistics, or supplier performance could delay unit deployments and impact the ability to meet the 10,000+ unit target. This is significant for Evolv because it lacks alternative manufacturing capacity and has high operating leverage.

AI and regulatory risks are also present. The EU AI Act , effective August 2024 with full provisions applying from August 2027, categorizes AI systems by risk and imposes requirements on high-risk applications. While Evolv's weapons detection likely qualifies as high-risk, the company has not disclosed specific compliance costs. Furthermore, any failure in detection algorithms could expose the company to liability and damage the brand.

Customer concentration risk is amplified by the vertical market strategy. While diversification across six end markets appears prudent, the disclosure that Evolv Express is deployed in only 1% of US school buildings and low single-digits in healthcare suggests reliance on early adopters. The Gwinnett County contract contributed $3.8 million in 2025 revenue—if large education customers delay upgrades or switch providers, the impact would be notable. Competitors like Leidos (LDOS) have more diversified government contract portfolios that provide a different risk profile.

The competitive landscape is evolving. OSI Systems reported record Q2 2026 revenues of $464 million, up 11%, and is integrating AI into legacy systems. Smiths Detection launched AI-enhanced scanners in late 2025 claiming improved imaging speed. While Evolv's touchless approach is designed for civilian throughput, these incumbents have established regulatory approvals and global distribution. If they successfully retrofit AI capabilities into installed bases at lower cost, Evolv's greenfield advantage could be challenged.

Valuation Context: Pricing in Execution

At $6.03 per share, Evolv trades at a market capitalization of $1.08 billion and an enterprise value of $1.05 billion, representing 7.4x trailing twelve-month sales of $145.9 million. This stands at a premium to established competitors: OSI Systems trades at 2.5x sales, Leidos at 1.2x, and Smiths Detection at approximately 2.0x. The premium valuation implies investors are paying for Evolv's growth trajectory—40% in 2025 versus 11% for OSIS and 3% for Leidos.

The price-to-operating cash flow ratio of 57.9x is elevated, but this metric is less meaningful during a transition from cash burn to generation. The enterprise value-to-revenue multiple of 7.2x prices in the expectation that Evolv will achieve its 2026 revenue guidance of $172-178 million and expand margins. If the company delivers on these targets, the forward multiple compresses to approximately 6.0x, still premium but supported by 20-25% ARR growth.

Balance sheet strength provides valuation support. With $69 million in cash and $45 million in undrawn credit capacity against $30 million in debt, Evolv has liquidity to fund operations through the 2026 cash flow inflection point. The debt-to-equity ratio of 0.35 is conservative, and the company is in compliance with debt covenants including a minimum ARR threshold of $106 million.

The negative profit margin of -22.7% and return on equity of -27.9% reflect the company's investment phase, but the positive adjusted EBITDA margin of 7.6% in 2025 shows the path to profitability is emerging. For comparison, OSI Systems generates 8.5% profit margins and 18.3% ROE, while Leidos delivers 8.4% margins and 31.0% ROE. Evolv's valuation premium depends on achieving similar profitability while maintaining superior growth.

Conclusion: A Subscription Story Hinging on Execution Velocity

Evolv Technologies has positioned itself at the intersection of three trends: the normalization of weapons screening as mandatory infrastructure, the shift from hardware sales to recurring SaaS revenue, and the application of AI to solve the throughput-detection trade-off. The company's 40% revenue growth, EBITDA inflection to positive $11.1 million, and 21% ARR expansion in 2025 provide evidence that this positioning is translating into financial results. Regulatory tailwinds from California and potential Georgia legislation create a forced adoption curve that could accelerate market penetration.

However, the investment thesis is dependent on execution of the subscription model transition. The premium valuation at 7.4x sales prices in growth, margin expansion to high single digits, and cash flow positivity in H2 2026. Any slippage in the Plexus manufacturing ramp, field service cost control, or customer retention could impact margins and cash generation. The competitive moat around AI-sensor fusion and cloud analytics is real but remains subject to competition from larger incumbents retrofitting AI capabilities.

The variables that will determine success are ARR growth acceleration and the margin expansion trajectory. If Evolv exits 2026 with $150 million ARR growing 25% and expands EBITDA margins beyond 10%, the current valuation will appear justified. If ARR growth decelerates or margins remain pressured by eXpedite scaling costs and field service investments, the stock faces risk as the premium multiple compresses. Quarterly progression on recurring revenue quality and cash generation will be the primary indicators of the company's long-term trajectory.